$12.16
-$0.12 (-0.98%)
$11.61Day Range$12.91
Key Statistics
Market Cap
$598.86M
Shares Outstanding
49.2M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Feb 6, 2026
Round Lot
100
Locale
US
Trading Data
Day Open
$12.31
Day High
$12.91
Day Low
$11.61
Volume
146.3K
VWAP
$12.08
Prev Close
$12.28
Transactions
--
Acc. Volume
--
About AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Identifiers
- CIK
- 0002020932
- Composite FIGI
- BBG01ZPFZLR6
- Share Class FIGI
- BBG01ZPFZNN6
- Ticker Root
- AGMB
About AgomAb Therapeutics NV American Depositary Shares (AGMB) Stock
AgomAb Therapeutics NV American Depositary Shares (AGMB) closed the 2026-09-15 session at $12.16, down 0.98% versus the previous close (-0.12). The stock opened at $12.31 and traded between $11.61 and $12.91 during that session. Session trading volume was 146K shares. The volume-weighted average price (VWAP) is $12.08.
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
AgomAb Therapeutics NV American Depositary Shares has a market capitalization of $598.9 million. AGMB is listed on the XNAS exchange. The company employs approximately 62 people. The recorded listing date is 2026-02-06.
On this page you can find market AGMB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.